Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 25, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,831	8,234	7,125	6,824	7,635	9,007
Market Cap Growth	74.26%	15.57%	4.41%	-10.63%	-15.23%	35.62%
Enterprise Value	13,153	8,416	7,347	6,449	6,676	7,922
Last Close Price	210.01	137.67	125.95	122.13	134.53	166.78
PS Ratio	16.68	21.87	24.17	124.77	863.17	1059.02
PB Ratio	-	-75.24	-44.24	24.25	7.60	8.78
P/TBV Ratio	-	-	-	24.70	7.64	8.84
EV/Sales Ratio	17.34	22.35	24.92	117.92	754.73	931.41
Debt / Equity Ratio	-4.67	-8.10	-4.42	1.93	0.12	0.11
Asset Turnover	0.57	0.36	0.28	0.05	0.01	0.01
Inventory Turnover	0.30	0.18	0.26	0.12	-	-
Quick Ratio	0.70	0.81	0.62	1.06	7.03	13.75
Current Ratio	1.03	1.17	0.95	1.29	8.03	14.02
Return on Equity (ROE)	-	-	-818.43%	-101.69%	-44.54%	-58.36%
Return on Assets (ROA)	-7.69%	-17.38%	-29.73%	-32.29%	-27.35%	-24.95%
Return on Capital (ROIC)	-12.99%	-27.89%	-44.83%	-39.89%	-29.42%	-26.42%
Return on Capital Employed (ROCE)	-82.20%	-102.60%	-511.40%	-150.60%	-45.90%	-35.70%
Earnings Yield	-2.13%	-4.75%	-7.47%	-9.13%	-5.71%	-5.69%
FCF Yield	-1.01%	-3.87%	-7.29%	-7.99%	-6.57%	-3.96%
Buyback Yield / Dilution	-5.56%	-2.85%	-0.38%	-2.37%	-8.21%	-8.84%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q